An international team of scientists led by the University of Bath studied evolutionary differences between mammal species and found that those with bigger brains and longer lifespans tend to invest more heavily in immune-related genes.
Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and those who have suffered severe trauma, such as burns, blast injuries, or natural disaster victims.
This facility ushers in a new era of gene and cell therapies to tackle scientific challenges such as targeted gene expression, immune system modulation, and long-term cell survival. The work will span from boosting immune responses against cancer to ensuring that therapeutic proteins are saf
Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventi
Immunotherapy research primarily focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach.
Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that may be activated to stop the bacteria after they elicit an immune response.
Antidepressants, such as Prozac, are routinely used to treat mental health issues, but recent research reveals they may also protect against major infections and life-threatening sepsis. Scientists at the Salk Institute have now discovered how medications regulate the immune system and prote
Brain inflammation, while an important aspect of the immune response, plays a negative effect in Alzheimer's disease. Unlike the acute, short-lived inflammation that fights infection, the inflammation associated with Alzheimer's is chronic and persistent. Scientists have been trying to figur
Researchers from CCU and NCKU have discovered a new cancer signalling mechanism that enables pancreatic cancer cells to evade immune destruction and sustain tumour growth. The TIMP1-CD63 signalling pathway, along with DUSP2 deficiency, creates a self-perpetuating cycle that accelerates cance
The researchers have identified a rare type of immune cell, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses against cancer and other chronic infections.
Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.